Schedule of Earnings Per Share |
The
earnings (loss) per share accounting guidance is discussed in Note 1. The following table sets forth the computation of the Company’s
basic and diluted net earnings (loss) per share available to common stockholders (unaudited) for the three and six months ended June 30,
2023 and 2022:
Schedule of Earnings Per Share
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
|
|
Three Months Ended June 30, |
|
|
Six Months Ended June 30, |
|
|
|
2023 |
|
|
2022 |
|
|
2023 |
|
|
2022 |
|
Numerator |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) from continuing operations |
|
$ |
1,285,930 |
|
|
$ |
(499,841 |
) |
|
$ |
2,091,490 |
|
|
$ |
(2,765,973 |
) |
Deemed dividends |
|
|
- |
|
|
|
(194,951,624 |
) |
|
|
- |
|
|
|
(330,876,369 |
) |
Net income (loss) available to common stockholders, continuing operations |
|
|
1,285,930 |
|
|
|
(195,451,465 |
) |
|
|
2,091,490 |
|
|
|
(333,642,342 |
) |
Net loss from discontinued operations |
|
|
(8,097 |
) |
|
|
(3,945 |
) |
|
|
(8,097 |
) |
|
|
(5,379 |
) |
Net income (loss) available to common stockholders |
|
$ |
1,277,833 |
|
|
$ |
(195,455,410 |
) |
|
$ |
2,083,393 |
|
|
$ |
(333,647,721 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Denominator |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average number of shares of common stock outstanding during the period - basic |
|
|
29,934,322,257 |
|
|
|
1,702,149,425 |
|
|
|
29,845,095,738 |
|
|
|
858,169,865 |
|
Warrants |
|
|
- |
|
|
|
- |
|
|
|
6,335,103,465 |
|
|
|
- |
|
Preferred stock |
|
|
452,145,411,111 |
|
|
|
- |
|
|
|
452,234,637,630 |
|
|
|
- |
|
Weighted average number of shares of common stock outstanding during the period - diluted |
|
|
482,079,733,368 |
|
|
|
1,702,149,425 |
|
|
|
488,414,836,833 |
|
|
|
858,169,865 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net earnings (loss) available to common stockholders per share - basic: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.00 |
|
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.39 |
) |
Discontinued operations |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
Total basic |
|
$ |
0.00 |
|
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.39 |
) |
Net earnings (loss) available to common stockholders
per share - diluted: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations |
|
$ |
0.00 |
|
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.39 |
) |
Discontinued operations |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
|
|
(0.00 |
) |
Total diluted |
|
$ |
0.00 |
|
|
$ |
(0.11 |
) |
|
$ |
0.00 |
|
|
$ |
(0.39 |
) |
|
Schedule of Anti-dilutive Securities Excluded from Computation of Earnings Per Share |
Diluted
earnings (loss) per share excludes all dilutive potential shares if their effect is anti-dilutive.
For
the three months ended June 30, 2023 and 2022, the following potential common stock equivalents were excluded from the calculation of
diluted earnings (loss) per share as their effect was anti-dilutive:
Schedule of Anti-dilutive Securities Excluded from Computation of
Earnings Per Share
|
|
2023 |
|
|
2022 |
|
|
|
Three Months Ended June 30, |
|
|
|
2023 |
|
|
2022 |
|
Common stock warrants |
|
|
511,333,351,089 |
|
|
|
511,333,351,097 |
|
Convertible preferred stock |
|
|
- |
|
|
|
477,576,633,334 |
|
Convertible debentures |
|
|
28,777,833,333 |
|
|
|
28,777,833,333 |
|
Stock options |
|
|
26 |
|
|
|
26 |
|
Anti-dilutive
shares |
|
|
540,111,184,448 |
|
|
|
1,017,687,817,790 |
|
For the six months ended June
30, 2023 and 2022, the following potential common stock equivalents were excluded from the calculation of diluted earnings (loss) per
share as their effect was anti-dilutive:
|
|
2023 |
|
|
2022 |
|
|
|
Six Months Ended June 30, |
|
|
|
2023 |
|
|
2022 |
|
Common stock warrants |
|
|
504,998,247,624 |
|
|
|
511,333,351,097 |
|
Convertible preferred stock |
|
|
- |
|
|
|
477,576,633,334 |
|
Convertible debentures |
|
|
28,777,833,333 |
|
|
|
28,777,833,333 |
|
Stock options |
|
|
26 |
|
|
|
26 |
|
Anti-dilutive
shares |
|
|
533,776,080,983 |
|
|
|
1,017,687,817,790 |
|
|